Risk of major bleeding and stroke associated with the use of vitamin K antagonists, nonvitamin K antagonist oral anticoagulants and aspirin in patients with atrial fibrillation: a cohort study

Emilie M. Gieling, Hendrika A. van den Ham*, Hein van Onzenoort, Jacqueline Bos, Cornelis Kramers, Anthonius de Boer, Frank de Vries, Andrea M. Burden

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1844-1859
Number of pages16
JournalBritish Journal of Clinical Pharmacology
Volume83
Issue number8
DOIs
Publication statusPublished - Aug 2017

Keywords

  • anticoagulants
  • aspirin
  • atrial fibrillation
  • gastrointestinal haemorrhage
  • intracranial haemorrhage
  • stroke
  • HEART-RHYTHM-ASSOCIATION
  • WARFARIN
  • METAANALYSIS
  • DABIGATRAN
  • EFFICACY
  • SAFETY
  • RIVAROXABAN
  • POPULATION
  • TRIALS
  • PHARMACOLOGY

Cite this